Amarin Corp Plc (AMRN)

[Whalatane]

Gabor excellent DD as always.

I responded to Fishy's post .
I do acknowledge that RI is a closer approximate to the JELIS high TG/low HDL subgroup then I remembered.

But ...more important matters are afoot .

Its come to my attention :>) that JL has responded to one of my posts that came to his attention.

I'm surprised that his post has not generated more discussion.
Surely I'm not the only one reading them ?

Anyway his lines
"In this comparison we know the percentage in JELIS, as far as I know, we do not know the percentage in R-I. Also we do not know how much the inclusion of coronary interventions would effect the over all risk.. "

So Gabor , being the master of logic that you are

If we have no idea of the percentage of prior coronary intervention in R-IT how can we use the data from JELIS secondary to estimate benefit in R -IT

If 60% of those in RI are there based on prior coronary intervention ( my guess ) and only 30% in JL's subgroup are there on that basis ...in both placebo arms ....it would seem logical that the placebo cohort in RI could have twice the risk of the placebo cohort in JELIS.

As always , I await your enlighten'd perspective
Kiwi